Ocular Therapeutix Ownership | Who Owns Ocular Therapeutix?


OverviewForecastRevenueFinancialsChartTranscripts

Ocular Therapeutix Ownership Summary


Ocular Therapeutix is owned by 10.13% institutional investors, 2.81% insiders, and 87.06% retail investors. Fmr is the largest institutional shareholder, holding 18.42% of OCUL shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.81% of its assets in Ocular Therapeutix shares.

OCUL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOcular Therapeutix10.13%2.81%87.06%
SectorHealthcare Stocks 232.63%10.66%-143.29%
IndustryBiotech Stocks 382.12%10.42%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr31.79M18.42%$371.57M
Blackrock11.52M8.73%$78.80M
Blackrock funding, inc. /de15.60M8.33%$189.41M
Vr adviser13.16M7.63%$153.86M
Deep track capital, lp11.93M6.91%$139.49M
Vanguard group11.58M6.29%$140.52M
Avoro capital advisors10.25M5.94%$119.82M
Summer road11.11M5.93%$134.86M
Tcg crossover management6.12M3.54%$71.51M
Point72 asset management4.60M2.67%$53.79M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Summer road11.11M97.92%$134.86M
Acuta capital partners1.17M14.08%$13.62M
Vr adviser13.16M8.66%$153.86M
Deltec asset management2.49M5.00%$30.20M
Octagon capital advisors lp2.62M4.65%$30.67M
Deep track capital, lp11.93M3.89%$139.49M
Knoll capital management600.40K3.76%$7.02M
Tcg crossover management6.12M3.52%$71.51M
Logos global management lp3.25M3.41%$37.99M
Saturn v capital management1.15M2.95%$13.46M

Top Buyers

HolderShares% AssetsChange
Fmr31.79M0.02%12.18M
Blackrock funding, inc. /de15.60M0.00%5.05M
Blackrock11.52M0.00%3.46M
Alliancebernstein3.42M0.01%3.26M
Avoro capital advisors10.25M1.55%2.85M

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp11.93M3.89%-2.36M
Braidwell lp---2.24M
Great point partners---1.73M
Morgan stanley879.14K0.00%-1.59M
Summer road11.11M97.92%-1.47M

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp1.60M0.02%1.60M$18.72M
Driehaus capital management518.75K0.04%518.75K$6.06M
Axa investment managers439.88K0.01%439.88K$5.14M
Prescott group capital management313.00K0.35%313.00K$3.80M
Rock springs capital management lp300.00K0.20%300.00K$3.51M

Sold Out

HolderChange
Parallel advisors-1.00
Financial gravity asset management-1.00
Federated hermes-2.00
Twin peaks wealth advisors-2.00
Nelson, van denburg & campbell wealth management group-17.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202560-73.68%18,632,527-90.10%100.09%31-74.59%17-71.67%
Sep 30, 202570-63.92%30,539,013-80.55%170.21%28-71.43%23-51.06%
Jun 30, 2025192-4.48%156,898,61016.16%901.43%963.23%47-20.34%
Mar 31, 20252028.60%137,366,9062.63%811.26%93-1.06%6057.89%
Dec 31, 20241772.31%128,615,765-8.11%771.10%8914.10%36-21.74%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S12.65M5.81%58.29K
Fidelity Growth Company Fund9.41M4.32%-53.02K
Vanguard Total Stock Mkt Idx Inv6.49M2.98%21.30K
Vanguard US Total Market Shares ETF4.64M2.92%-
iShares Russell 2000 ETF4.49M2.06%2.83M
Fidelity Growth Company K62.67M1.23%-5.27K
Fidelity Series Growth Company2.53M1.16%-
Vanguard Institutional Extnd Mkt Idx Tr1.84M0.85%3.43K
Fidelity Small Cap Index1.76M0.81%8.58K
iShares Russell 2000 Growth ETF1.55M0.71%896.38K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 23, 2026Dugel Pravin See RemarksSell$166.06K
Feb 23, 2026Kaiser Peter Chief Development OfficerSell$23.27K
Feb 23, 2026Heier Jeffrey S. Chief Scientific OfficerSell$25.31K
Feb 23, 2026Nayak Sanjay Chief Strategy OfficerSell$14.56K
Feb 20, 2026Waheed Nadia Chief Medical OfficerSell$27.17K

Insider Transactions Trends


DateBuySell
2026 Q1111
2025 Q4-8
2025 Q3-5
2025 Q215
2025 Q1-6

OCUL Ownership FAQ


Who Owns Ocular Therapeutix?

Ocular Therapeutix shareholders are primarily institutional investors at 10.13%, followed by 2.81% insiders and 87.06% retail investors. The average institutional ownership in Ocular Therapeutix's industry, Biotech Stocks , is 382.12%, which Ocular Therapeutix falls below.

Who owns the most shares of Ocular Therapeutix?

Ocular Therapeutix’s largest shareholders are Fmr (31.79M shares, 18.42%), Blackrock (11.52M shares, 8.73%), and Blackrock funding, inc. /de (15.6M shares, 8.33%). Together, they hold 35.48% of Ocular Therapeutix’s total shares outstanding.

Does Blackrock own Ocular Therapeutix?

Yes, BlackRock owns 8.73% of Ocular Therapeutix, totaling 11.52M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 78.8M$. In the last quarter, BlackRock increased its holdings by 3.46M shares, a 42.87% change.

Who is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested?

Summer road is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested, with 97.92% of its assets in 11.11M Ocular Therapeutix shares, valued at 134.86M$.

Who is the top mutual fund holder of Ocular Therapeutix shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Ocular Therapeutix shares, with 5.81% of its total shares outstanding invested in 12.65M Ocular Therapeutix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools